Disentangling Heterogeneity in Alzheimer's Disease: Two Empirically-Derived Subtypes.

ABSTRACT:

Background

Clinical-pathological Alzheimer's disease (AD) subtypes may help distill heterogeneity in patient presentation. To date, no studies have utilized neuropsychological and biological markers to identify preclinical subtypes with longitudinal stability.

Objective

The objective of this study was to empirically derive AD endophenotypes using a combination of cognitive and biological markers.

Methods

Hierarchical cluster analysis grouped dementia-free older adults using memory, executive and language abilities, and cerebrospinal fluid amyloid-β and phosphorylated tau. Brain volume differences, neuropsychological trajectory, and progression to dementia were compared, controlling for age, gender, education, and apolipoprotein E4 (ApoE4).

Results

Subgroups included asymptomatic-normal (n = 653) with unimpaired cognition and subthreshold biomarkers, typical AD (TAD; n = 191) showing marked memory decline, high ApoE4 rates and abnormal biomarkers, and atypical AD (AAD; n = 132) with widespread cognitive decline, intermediate biomarker levels, older age, less education and more white matter lesions. Cognitive profiles showed longitudinal stability with corresponding patterns of cortical atrophy, despite nearly identical rates of progression to AD dementia.

Conclusion

Two clinical-pathological AD subtypes are identified with potential implications for preventative efforts.

SUBMITTER: Blanken AE 

PROVIDER: S-EPMC8820245 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature